1. Home
  2. RVPH vs MXC Comparison

RVPH vs MXC Comparison

Compare RVPH & MXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • MXC
  • Stock Information
  • Founded
  • RVPH 2006
  • MXC 1972
  • Country
  • RVPH United States
  • MXC United States
  • Employees
  • RVPH N/A
  • MXC N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • MXC Oil & Gas Production
  • Sector
  • RVPH Health Care
  • MXC Energy
  • Exchange
  • RVPH Nasdaq
  • MXC Nasdaq
  • Market Cap
  • RVPH 18.1M
  • MXC 18.4M
  • IPO Year
  • RVPH N/A
  • MXC N/A
  • Fundamental
  • Price
  • RVPH $0.68
  • MXC $9.29
  • Analyst Decision
  • RVPH Strong Buy
  • MXC
  • Analyst Count
  • RVPH 6
  • MXC 0
  • Target Price
  • RVPH $4.50
  • MXC N/A
  • AVG Volume (30 Days)
  • RVPH 16.9M
  • MXC 4.5K
  • Earning Date
  • RVPH 11-13-2025
  • MXC 11-06-2025
  • Dividend Yield
  • RVPH N/A
  • MXC 1.08%
  • EPS Growth
  • RVPH N/A
  • MXC 44.21
  • EPS
  • RVPH N/A
  • MXC 0.79
  • Revenue
  • RVPH N/A
  • MXC $7,444,407.00
  • Revenue This Year
  • RVPH N/A
  • MXC N/A
  • Revenue Next Year
  • RVPH N/A
  • MXC N/A
  • P/E Ratio
  • RVPH N/A
  • MXC $11.35
  • Revenue Growth
  • RVPH N/A
  • MXC 13.06
  • 52 Week Low
  • RVPH $0.25
  • MXC $5.89
  • 52 Week High
  • RVPH $4.28
  • MXC $16.00
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 65.12
  • MXC 52.80
  • Support Level
  • RVPH $0.29
  • MXC $8.42
  • Resistance Level
  • RVPH $0.86
  • MXC $9.46
  • Average True Range (ATR)
  • RVPH 0.07
  • MXC 0.41
  • MACD
  • RVPH 0.05
  • MXC -0.03
  • Stochastic Oscillator
  • RVPH 72.03
  • MXC 54.89

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

About MXC Mexco Energy Corporation

Mexco Energy Corporation is an independent oil and gas company. It is engaged in the acquisition, exploration, development, and production of natural gas and crude oil properties located in the United States. The company carried out its operation in the Permian Basin of West Texas. It is focusing on two primary areas, the Delaware Basin located in the Western portion of the Permian Basin including Lea and Eddy Counties, New Mexico and Loving County, Texas, and the Midland Basin located in the Eastern portion of the Permian Basin including Reagan, Upton, Midland, Martin, Howard, and Glasscock Counties, Texas. The company generates revenue from Oil sales, Natural gas sales, oil and gas royalty interests.

Share on Social Networks: